<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343032">
  <stage>Registered</stage>
  <submitdate>6/06/2011</submitdate>
  <approvaldate>9/06/2011</approvaldate>
  <actrnumber>ACTRN12611000594921</actrnumber>
  <trial_identification>
    <studytitle>Percutaneous Nephrostomy versus Ureteroscopic Management of Sepsis Associated with Ureteral Stone Impaction: A Randomized Controlled Trial</studytitle>
    <scientifictitle>the efficacy, related complications and convalescence of retrograde ureteroscopic management instead of percutaneous nephrostomy for decompression of the collecting system in cases of sepsis associated with ureteral stone impaction.</scientifictitle>
    <utrn>U1111-1121-8852</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>sepsis associated with ureteral stone impaction</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Emergency ureteroscopic lithotripsy of sepsis associated with ureteral stone impaction(Under laryngeal mask anesthesia and asymetric lithotomy position,retrograde ureteroscopic lithotripsy with lithoclast was done upon admission.The stone fragments were removed with stone grasper,the double-J catheter indwelled for internal drainage.it takes 30 minutes)</interventions>
    <comparator>Emergency percutaneous nephrostomy sepsis associated with ureteral stone impaction(Under local anesthesia,prone position and sonographic guided,percutaneous nephrostomy was done upon admission it will takes 20 minutes.After the sepsis resolved,elective retrograde ureteroscopic lithotripsy with lithoclast was done.The stone fragments were removed with stone grasper,the double-J catheter indwelled for internal drainage.it takes 30 minutes</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>time to normalization of WBC of 10,000/mm. or less</outcome>
      <timepoint>WBC of 10,000/mm</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>time to normalization of  body temperature of 37.4 degrees celsiusC or less by tympanic thermometer.</outcome>
      <timepoint>body temperature of 37.4 degrees celsius by tympanic thermometer</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>analgesic consumption(oral Ketolorac 10 mg three time per day for 1 week if needed)(total doses reported by patients)</outcome>
      <timepoint>oral Ketolorac 10 mg three time per day for 1 week following procedure)(total doses reported by patients)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>length of stay(days,data linkage to patient medical records)</outcome>
      <timepoint>days of admission(data linkage to patient medical records)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients presenting to the emergency room or admitted to the hospital with obstructing ureteral stones and clinical signs of sepsis</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>uncorrected coagulopathy, urethral or ureteral stricture, urinary diversion, pregnancy, solitary kidney, and unwillingness or impossibility to commit to the study follow-up protocol.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>numbered containers</concealment>
    <sequence>random numbers table</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2007</anticipatedstartdate>
    <actualstartdate>1/07/2007</actualstartdate>
    <anticipatedenddate>31/05/2012</anticipatedenddate>
    <actualenddate>31/05/2012</actualenddate>
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Taiwan, Province Of China</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Chung Jing Wang</primarysponsorname>
    <primarysponsoraddress>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</primarysponsoraddress>
    <primarysponsorcountry>Taiwan, Province Of China</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Chung Jing Wang</fundingname>
      <fundingaddress>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</fundingaddress>
      <fundingcountry>Taiwan, Province Of China</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A randomized trial with evaluation of  the efficacy, related complications and convalescence of retrograde ureteroscopic management instead of percutaneous nephrostomy for decompression of the collecting system in cases of sepsis associated with ureteral stone impaction.</summary>
    <trialwebsite />
    <publication>not yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>IRB STM</ethicname>
      <ethicaddress>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC
St Martin De Porres Hospital</ethicaddress>
      <ethicapprovaldate>1/04/2007</ethicapprovaldate>
      <hrec>STM-IRB-2007-16</hrec>
      <ethicsubmitdate>1/01/2007</ethicsubmitdate>
      <ethiccountry>Taiwan, Province Of China</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Chung-Jing Wang</name>
      <address>60058 No 565 Rd Ta-Ya Chia-Yi city,Taiwan ROC St Martin De Porres Hospital</address>
      <phone>886-5-2756000-1013</phone>
      <fax>886-5-2788535</fax>
      <email>jing@stm.org.tw</email>
      <country>Taiwan, Province Of China</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>